Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2008 1
2009 1
2012 2
2013 3
2014 2
2015 1
2016 3
2017 2
2018 2
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI.
Andreassen MMS, Goa PE, Sjøbakk TE, Hedayati R, Eikesdal HP, Deng C, Østlie A, Lundgren S, Bathen TF, Jerome NP. Andreassen MMS, et al. Among authors: eikesdal hp. MAGMA. 2020 Apr;33(2):317-328. doi: 10.1007/s10334-019-00778-8. Epub 2019 Sep 27. MAGMA. 2020. PMID: 31562584 Free PMC article.
BMP7 Signaling in TGFBR2-Deficient Stromal Cells Provokes Epithelial Carcinogenesis.
Eikesdal HP, Becker LM, Teng Y, Kizu A, Carstens JL, Kanasaki K, Sugimoto H, LeBleu VS, Kalluri R. Eikesdal HP, et al. Mol Cancer Res. 2018 Oct;16(10):1568-1578. doi: 10.1158/1541-7786.MCR-18-0120. Epub 2018 Jun 22. Mol Cancer Res. 2018. PMID: 29934328 Free PMC article.
Impaired lymphatic function accelerates cancer growth.
Steinskog ES, Sagstad SJ, Wagner M, Karlsen TV, Yang N, Markhus CE, Yndestad S, Wiig H, Eikesdal HP. Steinskog ES, et al. Among authors: eikesdal hp. Oncotarget. 2016 Jul 19;7(29):45789-45802. doi: 10.18632/oncotarget.9953. Oncotarget. 2016. PMID: 27329584 Free PMC article.
Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.
Ottestad L, Fronth L, Rajendiran S, Hege Aksnes L, Eikesdal HP, Støre Blix E, Ewertz M. Ottestad L, et al. Among authors: eikesdal hp. Acta Oncol. 2019 Mar;58(3):385-387. doi: 10.1080/0284186X.2019.1566771. Epub 2019 Feb 23. Acta Oncol. 2019. PMID: 30798641 No abstract available.
The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.
Austreid E, Lonning PE, Eikesdal HP. Austreid E, et al. Among authors: eikesdal hp. Expert Opin Pharmacother. 2014 Apr;15(5):681-700. doi: 10.1517/14656566.2014.885952. Epub 2014 Feb 28. Expert Opin Pharmacother. 2014. PMID: 24579888 Review.
Drug resistance associated with antiangiogenesis therapy.
Eikesdal HP, Kalluri R. Eikesdal HP, et al. Semin Cancer Biol. 2009 Oct;19(5):310-7. doi: 10.1016/j.semcancer.2009.05.006. Epub 2009 Jun 11. Semin Cancer Biol. 2009. PMID: 19524042 Free PMC article. Review.
Lethal pneumonitis after docetaxel chemotherapy: case report and review of the literature.
Storaas E, Holmaas G, Gravdal K, Børretzen A, Eikesdal HP. Storaas E, et al. Among authors: eikesdal hp. Acta Oncol. 2013 Jun;52(5):1034-8. doi: 10.3109/0284186X.2012.750734. Epub 2012 Dec 17. Acta Oncol. 2013. PMID: 23244676 Review. No abstract available.
Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.
Lønning PE, Eikesdal HP. Lønning PE, et al. Among authors: eikesdal hp. Endocr Relat Cancer. 2013 Jun 24;20(4):R183-201. doi: 10.1530/ERC-13-0099. Print 2013 Aug. Endocr Relat Cancer. 2013. PMID: 23625614 Free PMC article. Review.
[Dental health when using bisphosphonates against breast cancer].
Eikesdal HP, Løes S, Herlofson BB. Eikesdal HP, et al. Tidsskr Nor Laegeforen. 2014 Aug 19;134(15):1451. doi: 10.4045/tidsskr.14.0717. eCollection 2014 Aug 19. Tidsskr Nor Laegeforen. 2014. PMID: 25138400 Free article. Norwegian. No abstract available.
Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC, Wagner M, Straume O, Bjerkvig R, Eikesdal HP. Johannessen TC, et al. Among authors: eikesdal hp. Expert Opin Ther Targets. 2013 Jan;17(1):7-20. doi: 10.1517/14728222.2013.730522. Epub 2012 Nov 2. Expert Opin Ther Targets. 2013. PMID: 23121690 Review.
20 results
Jump to page